ELAB
PMGC Holdings Inc.
There isn't enough reported data to score ELAB yet.
ELAB Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate ELAB's fundamentals.
ELAB PE Valuation
ELAB has no meaningful PE right now: it lost money over the past year.
ELAB Forward outlook
There aren't enough analyst estimates for ELAB to show an outlook.
ELAB Earnings Per Share
ELAB Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2025 | -769% | N/A |
| Q2 2024 | -233% | N/A |
| Q1 2024 | -274% | N/A |
ELAB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$2.1M | -$96.1K |
ELAB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +19% | +3 shares |
ELAB Net Leverage
ELAB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ELAB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 14.2 | Oversold |
| Stochastic | 1.3 | Oversold |
ELAB's weekly RSI is 14 (oversold) and its Stochastic is 1 (oversold).
ELAB PE vs Healthcare Sector
ELAB has no meaningful PE right now: it lost money over the past year.
ELAB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.79 | 43% below |
| 20 week MA | $5.95 | 73% below |
| 50 week MA | $306.5 | 99% below |
| 100 week MA | $8,594.8 | 100% below |
ELAB is in a downtrend: it's below all four of its weekly moving averages, and 100% below its 100-week average.
ELAB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $17,404,800.0 | $8,596,560.0 | -51% |
| 2024 | $8,596,560.0 | $57,388.8 | -99% |
| 2025 | $57,388.8 | $1,488.0 | -97% |
| 2026 YTD | $1,488.0 | $1.59 | -100% |
ELAB has finished every year since 2023 lower, and it's down 100% so far in 2026.